These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 12948853)
1. The novel nucleoside transport system exhibited by NB4 cells, csg, transports deoxyguanosine analogues, including ara-G. Flanagan SA; Gandhi V; Secrist JA; Meckling KA Biochem Pharmacol; 2003 Sep; 66(5):733-7. PubMed ID: 12948853 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. Shewach DS; Daddona PE; Ashcraft E; Mitchell BS Cancer Res; 1985 Mar; 45(3):1008-14. PubMed ID: 3971358 [TBL] [Abstract][Full Text] [Related]
3. Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acid. Flanagan SA; Meckling KA Leuk Res; 2007 Jul; 31(7):955-68. PubMed ID: 17045336 [TBL] [Abstract][Full Text] [Related]
4. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells. Rodriguez CO; Legha JK; Estey E; Keating MJ; Gandhi V Clin Cancer Res; 1997 Nov; 3(11):2107-13. PubMed ID: 9815603 [TBL] [Abstract][Full Text] [Related]
6. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems. King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483 [TBL] [Abstract][Full Text] [Related]
8. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx. Prus KL; Averett DR; Zimmerman TP Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735 [TBL] [Abstract][Full Text] [Related]
10. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Verhoef V; Fridland A Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098 [TBL] [Abstract][Full Text] [Related]
11. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells. Flanagan SA; Meckling KA Cancer Chemother Pharmacol; 2003 May; 51(5):363-75. PubMed ID: 12736759 [TBL] [Abstract][Full Text] [Related]
12. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine. Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163 [TBL] [Abstract][Full Text] [Related]
13. Nelarabine. Sanford M; Lyseng-Williamson KA Drugs; 2008; 68(4):439-47. PubMed ID: 18318562 [TBL] [Abstract][Full Text] [Related]
14. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684 [TBL] [Abstract][Full Text] [Related]
15. Guanosine acts intracellularly to initiate apoptosis in NB4 cells: A role for nucleoside transport. Flanagan SA; Gandhi V; Meckling KA Leuk Lymphoma; 2007 Sep; 48(9):1816-27. PubMed ID: 17786719 [TBL] [Abstract][Full Text] [Related]
16. Preclinical antitumor activity of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C). Waud WR; Gilbert KS; Shepherd RV; Montgomery JA; Secrist JA Cancer Chemother Pharmacol; 2003 May; 51(5):422-6. PubMed ID: 12679884 [TBL] [Abstract][Full Text] [Related]
17. Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine. Månsson E; Stridh H; Albertioni F Biochem Biophys Res Commun; 2002 Nov; 298(3):338-44. PubMed ID: 12413945 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C. Tiwari KN; Shortnacy-Fowler AT; Cappellacci L; Parker WB; Waud WR; Montgomery JA; Secrist JA Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):329-40. PubMed ID: 10772718 [TBL] [Abstract][Full Text] [Related]
19. 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies. Lambe CU; Averett DR; Paff MT; Reardon JE; Wilson JG; Krenitsky TA Cancer Res; 1995 Aug; 55(15):3352-6. PubMed ID: 7614470 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine. Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]